Comment on: Pristinamycin in the treatment of MSSA bone and joint infection.

2.50
Hdl Handle:
http://hdl.handle.net/11287/615788
Title:
Comment on: Pristinamycin in the treatment of MSSA bone and joint infection.
Authors:
Plant, Aiden J.; Auckland, Cressida
Citation:
Comment on: Pristinamycin in the treatment of MSSA bone and joint infection. 2016: J. Antimicrob. Chemother.
Publisher:
Oxford Journals
Journal:
The Journal of antimicrobial chemotherapy
Issue Date:
30-Jun-2016
URI:
http://hdl.handle.net/11287/615788
DOI:
10.1093/jac/dkw256
PubMed ID:
27365185
Additional Links:
http://jac.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=27365185
Type:
Comment; Letter
Language:
en
ISSN:
1460-2091
Appears in Collections:
Exeter Clinical Laboratory International (Blood Sciences, Genetics, Cellular Pathology & Microbiology); 2016 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorPlant, Aiden J.en
dc.contributor.authorAuckland, Cressidaen
dc.date.accessioned2016-07-08T10:43:07Z-
dc.date.available2016-07-08T10:43:07Z-
dc.date.issued2016-06-30-
dc.identifier.citationComment on: Pristinamycin in the treatment of MSSA bone and joint infection. 2016: J. Antimicrob. Chemother.en
dc.identifier.issn1460-2091-
dc.identifier.pmid27365185-
dc.identifier.doi10.1093/jac/dkw256-
dc.identifier.urihttp://hdl.handle.net/11287/615788-
dc.languageENG-
dc.language.isoenen
dc.publisherOxford Journalsen
dc.relation.urlhttp://jac.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=27365185en
dc.rightsArchived with thanks to The Journal of antimicrobial chemotherapyen
dc.subjectWessex Classification Subject Headings::Microbiology. Immunologyen
dc.titleComment on: Pristinamycin in the treatment of MSSA bone and joint infection.en
dc.typeCommenten
dc.typeLetteren
dc.identifier.journalThe Journal of antimicrobial chemotherapyen
dc.type.versionIn press (epub ahead of print)en

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.